Overview

Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
Effects of VEGF Trap-Eye (aflibercept) in treatment-naive polypoidal choroidal vasculopathy (PCV) will be evaluated.
Phase:
Phase 4
Details
Lead Sponsor:
Pusan National University Hospital
Collaborator:
Bayer
Treatments:
Aflibercept